Dynavax Technologies
DVAX
#5002
Rank
โ‚น169.77 B
Marketcap
โ‚น1,446
Share price
0.00%
Change (1 day)
16.54%
Change (1 year)

Earnings for Dynavax Technologies (DVAX)

Earnings in 2025 (TTM): -โ‚น2.79 Billion

According to Dynavax Technologies 's latest financial reports the company's current earnings are โ‚น0.33 Billion. In 2024 the company made an earning of โ‚น3.51 Billion, an increase over its 2023 earnings that were of โ‚น0.22 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Dynavax Technologies from 2004 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚น2.79 Billion-179.36%
2024 โ‚น3.51 B1475.31%
2023 โ‚น0.22 B-99.2%
2022 โ‚น28.02 B238.78%
2021 โ‚น8.27 B-257.89%
2020 -โ‚น5.25 Billion-58.58%
2019 -โ‚น12.66 Billion-9.32%
2018 -โ‚น13.96 Billion60.44%
2017 -โ‚น8.7 Billion-15.8%
2016 -โ‚น10.33 Billion4.22%
2015 -โ‚น9.91 Billion16.54%
2014 -โ‚น8.51 Billion37.09%
2013 -โ‚น6.21 Billion
2010 -โ‚น4.44 Billion214.85%
2009 -โ‚น1.41 Billion-37.33%
2008 -โ‚น2.25 Billion-66.07%
2007 -โ‚น6.64 Billion16.92%
2006 -โ‚น5.68 Billion170.36%
2005 -โ‚น2.1 Billion33.39%
2004 -โ‚น1.58 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚น649.97 B-20,661.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น1.030 T-32,713.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚น41.51 B-1,413.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-โ‚น236.28 Billion 7,374.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น627.12 B-19,938.88%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น1.407 T-44,626.09%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
โ‚น667.36 B-21,212.10%๐Ÿ‡ฌ๐Ÿ‡ง UK
Agenus
AGEN
โ‚น14.08 B-545.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น114.17 B-3,711.90%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel